Sildenafil citrate, commonly known by the brand name, is a prescription-only medicine used to treat erectile dysfunction (ED) in adult men. It works by improving blood flow to the penis, helping to achieve and maintain an erection during sexual activity.
Sildenafil is available in 25mg, 50mg, and 100mg strengths.
Sildenafil has been shown to be effective in up to 80% of men with ED, with effects typically noticeable within 30 to 60 minutes, and lasting for up to 4–5 hours.
Common side effects include:
Less common but serious effects include visual disturbances, hearing changes, or prolonged erections. Seek medical attention if severe or persistent side effects occur.
Sildenafil should not be used by those:
Inform your doctor of all medications and supplements before use. Interactions may occur with:
Avoid excessive alcohol while taking sildenafil, as it can lower blood pressure and increase side effect risk. Use with caution if you have any heart-related conditions.
Sildenafil is available by prescription only in the UK.
Don’t let ED affect your confidence or relationships. Buy Sildenafil tablets online today and experience more satisfying erections — securely, discreetly, and from our trusted UK-regulated pharmacy.
✅ Free online consultation✅ Fast UK delivery✅ Discreet packaging✅ GPhC-regulated
now and get back to enjoying intimacy with confidence.
Store Notice: Orders placed after 11:00 AM on Friday, 23 May 2025 will be processed on the next working day, Tuesday, 27 May 2025, due to the bank holiday weekend. Thank you for your understanding.
ShareLike onFacebook unveilsThe incredible benefits of ordering from one of the most dependable online pharmacies in the UK, Sildenafil is now available for purchase on the Highstreet Online Doctor service.
Convenient online ordering service offers a discreet and convenient way to get high-quality ED medicines, including Sildenafil. Our doctor will issue a prescription and you will receive it discreetly, conveniently, and discreetly.
....
For further information and support, please call or email us. If you are in need of advice or an appointment, please speak with our team at our London London branch.
Posted inon, has widens the lines of quality and service at the lowest possible prices in the UK.The drug company Pfizer has launched a campaign to raise the cost of its erectile dysfunction treatment Viagra (sildenafil citrate) in the US. In a statement, Pfizer said it was “helping to set realistic expectations” for the drug, which had been the world’s best selling medication for more than 20 years. It has already faced competition from rival generic competitors Pfizer Inc., Eli Lilly and Co. and Bayer AG.
Viagra is a “super-drug”, the company said, which is used to treat “impotence and erectile dysfunction”. It also is used to treat pulmonary arterial hypertension (PAH) when the blood pressure in the arteries is higher than what is needed.
The drug is not licensed in the US and is not being used as a treatment for erectile dysfunction, but as a lifestyle choice to improve a man’s sexual performance and libido.
In March, the US Food and Drug Administration (FDA) approved a generic version of Pfizer’s erectile dysfunction drug, sildenafil citrate, to treat PAH and impotence. The drug is also used to treat high blood pressure in the lungs, a condition that is sometimes treated with nitrates.
The company has already launched a campaign to raise the cost of Viagra in the US and has been working with the consumer advocacy group Cephalon to help to set realistic expectations for its drug. In a statement, Pfizer said it had been working on ways to “increase patient awareness and support”.
A spokesman for Pfizer, Eli Lilly & Co. and Bayer, who are the brands in the erectile dysfunction drug’s portfolio, said: “Our goal with Viagra is to help men feel better and have a fulfilling sex life.”
It is important for patients and doctors to have a clear understanding of the potential side effects, including dizziness and headache, which can be very dangerous for some people. In addition, the drug is contraindicated in pregnancy, as it can affect the developing fetus.
Pfizer has also been working with the National Institutes of Health to develop better ways to treat sexual dysfunction and improve sexual relationships. The company is also working on a new drug for the treatment of benign prostatic hyperplasia, or BPH, which is a condition that affects men with the condition. It is also looking at ways to increase the number of patients on dialysis for cancer treatment, which is also a treatment for high blood pressure in the lungs.
Pfizer’s Viagra campaignThe drug’s launch comes at a time when Pfizer is facing huge competition from rival generic drugs, which are used to treat erectile dysfunction. And it’s expected that a generic version of the drug will be available in the US on the same day. The drug was developed and approved by Pfizer in 1998, the first time it has been made available in the US.
Pfizer has been struggling with a generic version of Viagra for years, with patent expirations. The drug was the first in a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, which work by increasing blood flow to the penis, thereby helping men to get an erection. Viagra, which was available as a generic version in the US, will be available starting in the spring of 2009.
Pfizer said it had been working with the FDA and regulatory agencies on ways to reduce the cost of the drug. It said it was “working closely with the FDA and regulatory agencies to make a determination on the best way to bring Viagra to market”. It is also looking into the drug’s potential to increase sexual activity and increase a man’s overall satisfaction. Viagra has also been linked to a potentially fatal heart-related side effect called tachycardia.
The drugmaker has also been looking at ways to improve the lives of some people struggling with erectile dysfunction. It is hoping that one of the new ways it can help improve sexual performance and libido is by improving blood flow to the penis.
The drug’s launch comes at a time when Pfizer is facing huge competition from rival generic drugs, which are used to treat impotence and erectile dysfunction.
Phosphodiesterase (PDE) inhibitors, including sildenafil citrate and vardenafil, are the primary treatment options for erectile dysfunction. However, the development and marketing of PDE inhibitors have been limited by their inability to address a large majority of patients' needs. The development of new and improved PDE inhibitors has been a significant driver of the market. PDE inhibitors have shown efficacy, tolerability, and safety for treating erectile dysfunction. However, clinical trials with PDE inhibitors have shown mixed results. The FDA has approved several new PDE inhibitors for the treatment of erectile dysfunction, including sildenafil citrate. However, more than half of men who take sildenafil, including those on sildenafil citrate, have difficulty achieving and maintaining an erection sufficient for sexual intercourse. Other PDE inhibitors such as vardenafil and tadalafil have been studied for the treatment of erectile dysfunction. These agents have shown efficacy in treating the symptoms of erectile dysfunction. However, they have some side effects such as headache, dizziness, and flushing.
PDE inhibitors have been the subject of many large clinical trials. The first PDE inhibitor, Viagra, was FDA-approved in 1998. Since then, PDE inhibitors have been studied and studied in the treatment of erectile dysfunction. Other PDE inhibitors have been studied in the treatment of erectile dysfunction. The most recent FDA approval of PDE inhibitors for erectile dysfunction is for use in men aged 18–64 years with erectile dysfunction. Currently approved PDE inhibitors are listed below.
Sildenafil Citrate
Sildenafil is a phosphodiesterase (PDE) inhibitor. Sildenafil has been shown to be effective in treating erectile dysfunction. Sildenafil citrate has been studied for its ability to address and prevent erectile dysfunction in men with erectile dysfunction. The FDA has approved sildenafil for the treatment of erectile dysfunction. However, research has shown that sildenafil may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Vardenafil
Vardenafil is an oral phosphodiesterase (PDE) inhibitor. Vardenafil has been studied for its effectiveness in treating erectile dysfunction. Vardenafil has been shown to be effective in treating erectile dysfunction. However, research has shown that Vardenafil may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Tadalafil
Tadalafil is an oral phosphodiesterase (PDE) inhibitor. Tadalafil has been studied for its ability to treat erectile dysfunction. Tadalafil has been studied for its ability to address and prevent erectile dysfunction in men with erectile dysfunction. However, research has shown that Tadalafil may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Silagra
Silagra is an oral phosphodiesterase (PDE) inhibitor. Silagra has been studied for its effectiveness in treating erectile dysfunction. However, research has shown that Silagra may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Clotrimazole
Clotrimazole is an oral phosphodiesterase (PDE) inhibitor. Clotrimazole has been studied for its ability to address and prevent erectile dysfunction. However, research has shown that Clotrimazole may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Erythromycin
Erythromycin is an oral phosphodiesterase (PDE) inhibitor. Erythromycin has been studied for its ability to address and prevent erectile dysfunction. However, research has shown that Erythromycin may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Empagliflozin
Empagliflozin is an oral phosphodiesterase (PDE) inhibitor. Empagliflozin has been studied for its ability to address and prevent erectile dysfunction. However, research has shown that Empagliflozin may not be as effective as the standard first-line PDE inhibitors in treating erectile dysfunction.
Ketoconazole
Ketoconazole is an oral PDE inhibitor.
Note: Other medications can affect how Sildenafil is processed in your body, potentially impacting its effectiveness. These include azole antifungals (such as itraconazole or ketoconazole), macrolide antibiotics (such as clarithromycin or erythromycin), HIV protease inhibitors (such as saquinavir), mifepristone, rifampin, and ritonavir.
Combining Sildenafil with other medications for erectile dysfunction (ED) or pulmonary hypertension, such as tadalafil or vardenafil, is harmful.
esar de necesitudere
Stade de France Pharmacy